114 related articles for article (PubMed ID: 1331158)
1. Quantitative flow cytometry of mouse mammary tumor virus envelope glycoprotein (gp52): alternative measures of hormone-mediated change in a viral cell surface antigen.
Ritzi EM
J Virol Methods; 1992 Oct; 40(1):11-30. PubMed ID: 1331158
[TBL] [Abstract][Full Text] [Related]
2. Quantitative flow cytometry reveals a hierarchy of glucocorticoid effect on cell surface mouse mammary tumor virus gp52.
Ritzi EM
J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):33-42. PubMed ID: 8645615
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids stimulate the release of a viral tumor marker (MMTV gp52) while inhibiting tumor cell growth.
Ritzi EM; Walthall EB
J Steroid Biochem; 1989 Apr; 32(4):499-505. PubMed ID: 2542692
[TBL] [Abstract][Full Text] [Related]
4. Positive and negative modification of dexamethasone-mediated MMTV gp52 release by progesterone pretreatment of tumor cells.
Ritzi EM; Walthall EB
Intervirology; 1989; 30(2):111-6. PubMed ID: 2542181
[TBL] [Abstract][Full Text] [Related]
5. Elevation of mouse mammary tumor virus envelope glycoprotein (Gp52) by growth factors.
Ritzi EM; Walthall EB
Intervirology; 1988; 29(3):144-53. PubMed ID: 2846465
[TBL] [Abstract][Full Text] [Related]
6. Detection and characterization of mouse mammary tumor virus cell surface antigens: estimation of antigen abundance by protein A assay.
Callis AH; Ritzi EM
J Virol; 1980 Sep; 35(3):876-87. PubMed ID: 6252344
[TBL] [Abstract][Full Text] [Related]
7. Estimation of mouse mammary tumor virus gp52 abundance by protein A assay: a comparison of viral antigen expression on C3H and GR mammary tumor cells.
Callis AH; Ritzi EM
Intervirology; 1981; 15(2):111-20. PubMed ID: 6271704
[TBL] [Abstract][Full Text] [Related]
8. Lipids alter the level and distribution of mouse mammary tumor virus gp52 in vitro.
Sunzeri FJ; Buehring GC
Cancer Lett; 1993 Oct; 74(1-2):57-64. PubMed ID: 8287372
[TBL] [Abstract][Full Text] [Related]
9. Shedding of virus-free MMTV gp52 by nonproducer mammary tumor cells: a source of tumor marker in the presence and absence of dexamethasone.
Ritzi EM; Walthall EB
Intervirology; 1989; 30(2):102-10. PubMed ID: 2542180
[TBL] [Abstract][Full Text] [Related]
10. Levels of viral glycoprotein reflect enhanced effectiveness of combined drug treatments.
Ritzi EM; Pyo S
Life Sci; 1994; 54(13):887-99. PubMed ID: 8139377
[TBL] [Abstract][Full Text] [Related]
11. Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52.
Schochetman G; Arthur LO; Long CW; Massey RJ
J Virol; 1979 Oct; 32(1):131-9. PubMed ID: 94356
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
Ritzi EM; Smith BA; Stolfi RL; Martin DS
Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
[TBL] [Abstract][Full Text] [Related]
13. Expression and disposition of the murine mammary tumor virus (MuMTV) envelope gene products by murine mammary tumor cells.
Sarkar NH; Racevskis J
Virology; 1983 Apr; 126(1):279-300. PubMed ID: 6302986
[TBL] [Abstract][Full Text] [Related]
14. Second messengers induced by the envelope protein of a retrovirus.
Bolander FF
Mol Cell Endocrinol; 1997 Apr; 129(1):27-32. PubMed ID: 9175626
[TBL] [Abstract][Full Text] [Related]
15. The effect of glucocorticoid on the subcellular localization, oligomerization, and processing of mouse mammary tumor virus envelope protein precursor Pr74.
Corey JL; Stallcup MR
Mol Endocrinol; 1992 Mar; 6(3):450-8. PubMed ID: 1316542
[TBL] [Abstract][Full Text] [Related]
16. The effects of 2-deoxyglucose and tunicamycin on the biosynthesis of the murine mammary tumor virus proteins, and on the assembly and release of the virus.
Sarkar NH
Virology; 1986 Apr; 150(2):419-38. PubMed ID: 3008416
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a C3Hf mammary tumor cell line expressing endogenous mouse mammary tumor virus: antigenic and genetic relationships of this virus with highly oncogenic mouse mammary tumor viruses.
Arthur LO; Lovinger GG; Schochetman G
J Virol; 1979 Dec; 32(3):852-9. PubMed ID: 92576
[TBL] [Abstract][Full Text] [Related]
18. Immunological characterization of mouse mammary tumor virus p10 and its presence in mammary tumors and sera of tumor-bearing mice.
Arthur LO; Fine DL
J Virol; 1979 Apr; 30(1):148-56. PubMed ID: 90156
[TBL] [Abstract][Full Text] [Related]
19. Levels of viral glycoprotein provide a dose-dependent measure of tumor cell inhibition.
Ritzi EM; Pyo S
Life Sci; 1989; 44(26):2041-50. PubMed ID: 2545986
[TBL] [Abstract][Full Text] [Related]
20. Morphologic and antigenic properties of mouse mammary tumor virus produced in a hormone-responsive fashion by C57Bl/10 mammary tumors of non-viral origin.
Marchetti A; Svec J; Hlavay E; Veselovska Z; Castagna M; Squartini F
Tumori; 1988 Jun; 74(3):261-7. PubMed ID: 2456634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
